Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-08 Option Award | 2023-09-12 4:08 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:07 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:07 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:06 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-09-08 Option Award | 2023-09-12 4:05 pm | N/A 2033-09-08 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 9:06 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 7:23 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 4:13 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Hirth Peter Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 4:11 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-20 Option Award | 2023-07-21 4:10 pm | N/A 2033-07-20 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:12 pm | N/A 2033-03-15 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:11 pm | N/A 2033-03-15 | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 78,750 | $0 | 78,750 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:11 pm | N/A 2033-03-15 | Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks | 78,750 | $0 | 78,750 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:10 pm | N/A 2033-03-15 | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 78,750 | $0 | 78,750 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:10 pm | N/A 2033-03-15 | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 169,500 | $0 | 169,500 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-17 4:09 pm | N/A 2033-03-15 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 242,500 | $0 | 242,500 (Direct) | View |
| 2022-07-07 Option Award | 2022-07-11 4:15 pm | N/A 2032-07-07 | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 46,000 | $0 | 46,000 (Direct) | View |
| 2022-07-07 Option Award | 2022-07-11 4:15 pm | N/A 2032-07-07 | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 52,500 | $0 | 52,500 (Direct) | View |
| 2022-07-07 Option Award | 2022-07-11 4:14 pm | N/A 2032-07-07 | Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks | 52,500 | $0 | 52,500 (Direct) | View |
| 2022-07-07 Option Award | 2022-07-11 4:13 pm | N/A 2032-07-07 | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 113,000 | $0 | 113,000 (Direct) | View |
| 2022-07-07 Option Award | 2022-07-11 4:13 pm | N/A 2032-07-07 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 161,700 | $0 | 161,700 (Direct) | View |
| 2022-07-07 Option Award | 2022-07-11 4:12 pm | N/A 2032-07-07 | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:14 pm | N/A 2032-06-23 | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:14 pm | N/A 2032-06-23 | Aligos Therapeutics Inc. | ALGS | Hirth Peter Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:13 pm | N/A 2032-06-23 | Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:13 pm | N/A 2032-06-23 | Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:12 pm | N/A 2032-06-23 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 4:11 pm | N/A 2032-06-23 | Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director | 15,000 | $0 | 15,000 (Direct) | View |
Ownership | 2022-05-06 4:12 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer | 0 | $0 | 515,478 (Indirect) | View |
| 2022-02-04 Option Award | 2022-02-08 4:09 pm | N/A 2032-02-04 | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 131,250 | $0 | 131,250 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:09 pm | N/A 2032-02-04 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE Chief Executive Officer | 404,250 | $0 | 404,250 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:08 pm | N/A 2032-02-04 | Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks | 131,250 | $0 | 131,250 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:07 pm | N/A 2032-02-04 | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 131,250 | $0 | 131,250 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 4:07 pm | N/A 2032-02-04 | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 283,500 | $0 | 283,500 (Direct) | View |
| 2021-11-16 Option Award | 2021-11-18 4:38 pm | N/A 2031-11-16 | Aligos Therapeutics Inc. | ALGS | Martell Bridget A Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-17 6:46 pm | N/A 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Nielsen Jack Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-17 5:14 pm | N/A 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-17 5:13 pm | N/A 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Hirth Peter Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-17 5:09 pm | N/A 2031-06-17 | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 15,000 | $0 | 15,000 (Direct) | View |